Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Eagle Pharmaceuticals Receives FDA Qualified Infectious Disease Product (QIDP) and Fast-Track Designation for CAL02, Providing Five-Year Exclusivity Extension
Thursday, June 15, 2023Eagle Pharmaceuticals Inc Nasdaq EGRX Eagle or the Company today announced that the US Food and Drug Administration FDA has granted Qualified Infectious Disease Product QIDP Designation under the Generating Antibiotic Incentives Now GAIN Act and Fast...
Correction: Ipsen announces U.S. FDA submission acceptance of its supplemental New Drug Application for Onivyde regimen in first-line metastatic pancreatic ductal adenocarcinoma
Thursday, June 15, 2023Ipsen Euronext IPN ADR IPSEY today announced that the US Food and Drug Administration FDA has accepted its supplemental new drug application sNDA Onivyde irinotecan liposome injection plus fluorouracilleucovorin and oxaliplatin NALIRIFOX regimen as...
Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe
Tuesday, June 13, 2023Endo International plc OTC ENDPQ announced today that its Par Sterile Products business has begun shipping PREVDUO neostigmine methylsulfate and glycopyrrolate injection prefilled syringe the first and only FDAapproved neostigmineglycopyrrolate combi...
Merck to Present Data for Efinopegdutide (MK-6024), an Investigational GLP-1/Glucagon Receptor Co-agonist, in Patients with Nonalcoholic Fatty Liver Disease (NAFLD) at EASL 2023
Tuesday, June 13, 2023Merck NYSE MRK known as MSD outside of the United States and Canada announced that new findings for efinopegdutide MK an investigational GLPglucagon receptor coagonist have been accepted for oral presentation at the European Association for the Study...
Intellia Therapeutics Announces New Positive Clinical Data from Phase 1 Study of NTLA-2002, an Investigational In Vivo CRISPR Genome Editing Treatment for Hereditary Angioedema (HAE)
Monday, June 12, 2023Intellia Therapeutics Inc NASDAQNTLA a leading clinicalstage genome editing company focused on developing potentially curative therapeutics leveraging CRISPRbased technologies today announced updated interim results from the Phase portion of the ong...
Chinook Therapeutics Enters into Agreement to be Acquired by Novartis AG
Monday, June 12, 2023Chinook Therapeutics Inc Nasdaq KDNY a biopharmaceutical company focused on the discovery development and commercialization of precision medicines for kidney diseases today announced that it has entered into an agreement and plan of merger with Novar...
Parse Biosciences Launches CRISPR Detect
Friday, June 09, 2023Bulk pooled CRISPR screening has been a valuable tool to understand gene function on a genome scale Adding single cell resolution to pooled CRISPR screens pairs individual gene perturbations with rich whole transcriptome expression phenotypes This ap...
Iktos and Curreio Announce Collaboration Agreement in New Drug Discovery
Friday, June 09, 2023Iktos a company specialized in Artificial Intelligence for new drug design and Curreio Inc Curreio a Japanese company specializing in structural analysis of biomolecules using cryoelectron microscopy today announced a collaboration agreement in AI fo...
Azafaros Announces Enrollment of First Patient in Phase 2 RAINBOW Study Evaluating AZ-3102 in GM2 and NP-C Patients
Friday, June 09, 2023Azafaros BV today announced that the first patient has been enrolled into its Phase RAINBOW study NCT The clinical trial is being conducted in Brazil and the US and will evaluate the safety tolerability pharmacokinetics and pharmacodynamics across t...
Productlife Group Announces Its Intention To Merge With Pharma D&s Group, Expanding Its Global Offer And Its Presence In Italy
Thursday, June 08, 2023ProductLife Group takes a key step in its growth with the acquisition of private Italian company Pharma DS Group Through this strategic alliance PLG a global provider of regulatory and compliance services for the life sciences industry strengthens it...
